Login to Your Account

The house that Innovent built
SHANGHAI – Innovent Biologics Inc. and its staff of 170 took occupancy of its $140 million facility in Suzhou's Biobay Industrial Park this month. The impressive facility designed with ancient fengshui principles in mind, houses two state-of-the-art 1,000-liter bioreactors. more »

Our Habitat for All Things Science
Promising compounds 'profoundly alter' disease course in SMA

Scientists from Roche Pharma Research and Early Development (pRED) and PTC Therapeutics Inc., with colleagues in academia, reported on small-molecule drugs that improved the symptoms of spinal muscular atrophy (SMA) by altering the splicing of the protein SMN2.

In mouse models of SMA, the compounds "profoundly altered the course of the disease," PTC Therapeutics CEO and co-author Stuart Peltz told BioWorld Today.



Partners in Focus